Mountain Manor has a long history of involvement in research to develop and test innovative approaches to addiction treatment. Our research group has conducted numerous projects both on its own and in collaboration with a variety of academic partners including Johns Hopkins University, Friends Research Institute, Dartmouth University and others.
Mountain Manor Treatment Centers Research and News
Projects at Mountain Manor have included several studies on the effectiveness of medication treatment for cocaine addiction and opioid addiction, studies of motivational incentives as a treatment for adolescent Cannabis use disorders, and studies on whether computerized cognitive rehabilitation training can improve outcomes for adolescent treatment. Other studies include examining the role of certain risk factors such as impulsiveness in the outcomes of youth opioid addiction.
Our research group led by Marc Fishman MD, Mountain Manor’s Medical Director, and Hoa Vo PhD, Research Scientist, has published numerous journal articles and book chapters on many topics in the addiction field, and continues to present regularly at national scientific meetings. Dr. Fishman is also a nationally recognized expert on addiction treatment and lectures widely on a variety of topics including youth treatment, placement and treatment matching strategies, co-occurring disorders, and medication treatment for addiction.
Mountain Manor Treatment Centers is proud to be one of the core community treatment program partners of the Mid-Atlantic Node of the Clinical Trials Network (CTN) of the National Institute on Drug Abuse (NIDA). Dr. Fishman is a Co-Investigator for the Node faculty and a member of the CTN ‘s national Research Development Committee. Mountain Manor has been the site of several CTN studies, including an ongoing trial at our Avery Road Treatment Center program examining the effectiveness of Buprenorphine vs extended release Naltrexone for opioid addiction.
Under Dr. Fishman’s leadership, Mountain Manor achieved major recognition in 2010 by winning an iAward for innovation in behavioral health care, one of 10 awarded nationally from the State Associations of Addiction Services (SAAS) and the National Treatment Improvement Center (NiaTx) for its Mountain Manor Youth Opioid Treatment Program. And in 2012 MTC received one of the first SAMHSA Science to Service Awards for office based opioid treatment, including both excellence in treatment programming and documentation of treatment outcome data.
Mountain Manor’s Medical Director featured in article about the success of our medication-assisted treatment program
Click on the link below to read about one young adult’s experience receiving medication-assisted treatment at Mountain Manor Treatment Center in Baltimore.
“Butzner credits his medication with a loss of cravings for drugs.
‘I can’t get drunk. Why am I going to try? If I can’t get that high, I can’t chase it. If I can’t chase it, I can focus on my recovery,’ Butzner explains. ‘What I’m chasing is finally my own happiness.'”
Read more about his experience and learn more about the benefits of medication assisted therapy at Mountain Manor by clicking the link below!
Mountain Manor is pleased to announce the publication of an overview of youth opioid use disorders by our team of clinical and research experts. This chapter appears in the June 2016 issue of Psychiatric Clinics of North America, in a special issue on youth substance use disorders. The chapter describes clinical features of the current opioid epidemic in adolescents and young adults. Take home points include:
- The current epidemic of opioid use and addiction in adolescents and young adults is worsening, including heroin and nonmedical use of prescription opioids.
- Opioid use has devastating consequences for youth and their families, including: progression to full addiction, severe psychosocial impairment, hepatitis C virus and HIV transmission with injection use, exacerbation of co-occurring psychiatric disorders, overdose, and death.
- Progression of opioid use disorders (OUDs) in youth often follows a characteristic pattern from use of diverted prescription opioid analgesics to sniffed or smoked heroin to injection heroin.
- Opioid overdose is a life-threatening emergency. Respiratory depression should be treated with naloxone, and respiratory support if necessary. Overdose should always be utilized as an opportunity to initiate addiction treatment.
- Opioid withdrawal management (detoxification) is often a necessary, but never sufficient, component of treatment for OUDs. Medications used in the treatment of withdrawal may include buprenorphine, clonidine, and others for relief of symptoms.
- Treatment for OUDs is effective, but treatment capacity is alarmingly limited and underdeveloped.
- Emerging consensus supports the incorporation of relapse prevention medications such as buprenorphine and extended-release naltrexone into comprehensive psychosocial treatment including counseling and family involvement.
Click HERE to read the chapter!
Congratulations to Ken Weinberg, aka “Mr. Ken”, on 25 fabulous years with Mountain Manor!!!!
Loved by every patient he meets, Mr. Ken is the Program Director of Adolescent and Young Adult Outpatient services at Mountain Manor-Baltimore. He is also the Patient Advocate. Mr. Ken says the best part of his job is doing intakes because he is the first person who new patients meet and he gets to make a good first impression.
Ken likes forming a therapeutic bond with his patients and gets a real sense of accomplishment by influencing the kids in a good way and getting them to come back to him in his treatment groups . Mr. Ken has actually worked with the children of patients he treated years ago!
Thank you for all that you do for us, Mr. Ken!
New research-based marijuana treatment program for youth
Do you know an adolescent or young adult who has a problem with marijuana/ cannabis? Mountain Manor is pleased to announce an exciting new opportunity for adolescents with problematic marijuana use. As part of a study in collaboration with Dartmouth University at our Mountain Manor Baltimore program, we will begin offering a unique research-based approach to marijuana use disorders based on contingency management and working memory training. Contingency management (or motivational incentives) is a treatment that offers rewards for results. In this study, all participants will be given monetary rewards for negative urine drug tests. Additionally, half of the participants will be randomly assigned to do training with a computer program that strengthens working memory, a cognitive function that may be impaired in substance use disorders. Youth (ages 12-21) who enroll for outpatient treatment for problem marijuana/cannabis use at Mountain Manor are eligible for this incentives program. The program includes 14 weekly individual sessions that provide motivational support for making changes in substance use. 12 additional weeks of testing for substance use are provided with incentives for continued abstinence. The treatment program also offers counseling, mental health therapy, and psychiatric treatment. Evening and weekend appointments are available. Compensation is offered for participation in the study. Transportation may be available for qualifying participants.
Contact us today!
To schedule an assessment or get more information – Phone: (443) 750-2849 Email: firstname.lastname@example.org
Crackdown on synthetic pot has driven the dangerous drug to the streets
THE FAMILY EMPOWERMENT PROGRAM PRESENTS:
FREE Opioid Overdose Response Training
Saturday, January 16, 2016 10:00am-12:00pm
Who Should Attend?Family members, friends and associates of someone who is using and at risk for overdosing on heroin or prescription pain medications. Only participants 18 and older can become certified. Teens under 18 may take the training if accompanied by a parent or guardian; however, minors are not eligible for certification.
What Will I LearnTraining will incorporate the following information:
- What an opioid is
- How to recognize, respond to and prevent an opioid overdose
- How to administer the naloxone in the event of a suspected overdose